- A global shortage of two common intravenous (IV) contrast fluids is prompting some medical facilities to delay routine imaging procedures such as CT scans,
- Industry officials say the shortage is due to the temporary shutdown of a production facility in China.
- Experts say the delays may impact people who need diagnostic imaging tests.
- Medical facilities are being urged in some cases to use alternative procedures such as ultrasound technology.
Hospitals and medical facilities around the United States are rationing intravenous (IV) contrast imaging procedures amid a global shortage.
See also Global CO2 level hits record high in 2022 due to China manufacturing lithium batteries and solar panels with coal, shipping them to the West using diesel cargo ships.
The U.S. Food and Drug Administration has reported shortages of two forms of contrast medium fluids known as Iohexol and Iodixanol, both commonly used in CT scans.